Your browser doesn't support javascript.
loading
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
Schindewolf, Marc; Steindl, Julia; Beyer-Westendorf, Jan; Schellong, Sebastian; Dohmen, Pascal Maria; Brachmann, Johannes; Madlener, Katharina; Pötzsch, Bernd; Klamroth, Robert; Hankowitz, Johannes; Banik, Norbert; Eberle, Sonja; Müller, Markus Michael; Kropff, Stefan; Lindhoff-Last, Edelgard.
Afiliación
  • Schindewolf M; Department of Internal Medicine, Division of Hemostaseology, Goethe University Hospital Frankfurt, Frankfurt am Main, Germany; Swiss Cardiovascular Center, Division of Vascular Medicine, University Hospital Bern, Bern, Switzerland. Electronic address: Marc.Schindewolf@insel.ch.
  • Steindl J; Department of Internal Medicine, Division of Hemostaseology, Goethe University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Beyer-Westendorf J; Thrombosis Research Unit, Department of Medicine 1, Division of Hematology, University Hospital "Carl Gustav Carus" Dresden, Dresden, Germany; King's Thrombosis Service, Department of Hematology, King's College London, London, United Kingdom.
  • Schellong S; Medical Department II, Municipal Hospital Dresden, Dresden, Germany.
  • Dohmen PM; Department of Cardiovascular Surgery, Charité Hospital, Medical University Berlin, Berlin, Germany; Department of Cardiac Surgery, Heart Center Rostock, University of Rostock, Rostock, Germany.
  • Brachmann J; Department of Cardiology, II. Medical Clinic, Klinikum Coburg, Coburg, Germany.
  • Madlener K; Department of Hemostaseology and Transfusion Medicine, Kerckhoff-Klinik, Bad Nauheim, Germany.
  • Pötzsch B; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
  • Klamroth R; Department of Internal Medicine, Hemophilia Treatment Centre, Vivantes Klinikum im Friedrichshain Berlin, Berlin, Germany.
  • Hankowitz J; Institute of Pharmacology and Preventive Medicine, Munich, Germany.
  • Banik N; Biostatistics & Epidemiology, GlaxoSmithKline Germany, Munich, Germany; Winicker Norimed Medical Research GmbH, Munich, Germany.
  • Eberle S; Biostatistics & Epidemiology, GlaxoSmithKline Germany, Munich, Germany; Winicker Norimed Medical Research GmbH, Munich, Germany.
  • Müller MM; Internal Medicine III, GlaxoSmithKline Germany, Munich, Germany.
  • Kropff S; Internal Medicine III, GlaxoSmithKline Germany, Munich, Germany; Amgen, Munich, Germany.
  • Lindhoff-Last E; Department of Internal Medicine, Division of Hemostaseology, Goethe University Hospital Frankfurt, Frankfurt am Main, Germany; Cardiovascular Center Bethanien (CCB), Frankfurt am Main, Germany.
J Am Coll Cardiol ; 70(21): 2636-2648, 2017 Nov 28.
Article en En | MEDLINE | ID: mdl-29169470
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polisacáridos / Trombocitopenia / Heparina / Inhibidores del Factor Xa / Anticoagulantes Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Am Coll Cardiol Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polisacáridos / Trombocitopenia / Heparina / Inhibidores del Factor Xa / Anticoagulantes Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Am Coll Cardiol Año: 2017 Tipo del documento: Article